✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Trident Lifeline Ltd.

TLL

Market Cap
₹292 Cr.
P/E
15.31

Trident Lifeline Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
292 Cr
PE
PE
15.31
Prom Holding
Prom Holding
62.85 %
ROE (%)
ROE (%)
18.23
ROCE (%)
ROCE (%)
17.75
Div Yield (%)
Div Yield (%)
-
Sales
Sales
92.48 Cr
OPM (%)
OPM (%)
22.92 %
Debt to Equity
Debt to Equity
0.87
Institutions
Institutions
7.51 %
Individual < 2 lac
Individual < 2 lac
9.63 %
No. of Shareholders
No. of Shareholders
607
View more
Edit Ratio's

About

Trident Lifeline Limited is a pharmaceutical company involved in ethical marketing and distrib… Read more
Low
230
52W Range
High
328
  • Trident Lifeline
  • Medicamen Biotech
  • Gennex Lab

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

6 Yes

Positive for this company

0 Neutral

Neutral for this company

10 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • Advertisement Spend as a % of Total Sales (%)
      Source

    Peer Comparison

    FAQs on Trident Lifeline Ltd. Business

    Trident Lifeline Limited is a pharmaceutical company that focuses on ethical marketing of a variety of products domestically and internationally through a third-party network spanning multiple countries around the world.

    Trident Lifeline major competitors are Medicamen Biotech, Gennex Lab, Lyka Labs, Ambalal Sarabhai Ent, Shivalik Rasayan, Medico Remedies, Achyut Healthcare.
    Market Cap of Trident Lifeline is ₹292 Crs.
    While the median market cap of its peers are ₹255 Crs.

    Trident Lifeline seems to be less financially stable compared to its competitors.
    Altman Z score of Trident Lifeline is 2.51 and is ranked 7 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation Jan May Jul Nov Mar Jun Sep Mar Jun Sep Dec
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material